7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
features Clinical ... and Culture • CXR ... disease • Check CXR ... #Diagnosis #Management ... #Treatment #ActiveTB
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Tuberculosis #MDRTB #management ... #regimens #pharmacology ... #dosing #idsa #
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
features Clinical ... and Culture • CXR ... disease • Check CXR ... #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... HIV-AIDS Preventing Clinical ... patients with acute ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Bell's Palsy - Diagnosis and Management Summary - GrepMed Handbook

Acute Idiopathic Unilateral Facial Nerve (CN7) Palsy
Presentation:
Bell's Palsy - Diagnosis ... GrepMed Handbook Acute ... - Atypical Clinical ... ) • EMG/NCS (rare ... #Treatment #Neurology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Disseminated Disease)—Acute ... • Use until clinical ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... Note: Active TB ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology